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The article presents review of the most significant neurovisual biomarkers-predictors of the 
cognitive disfunction caused by brain vascular pathology. Also given quantitative and qualita-
tive characteristics of this pathology including localization that can be detected using routine 
and diffusion-tensor MRI. Following biomarkers were noted when using standard MRI pro-
tocols: atrophy of gray matter and white matter tracts and basal nuclei; white matter hyperin-
tensities (foci of gliosis and periventricular leukoaraiosis), micro-bleeding (large vessels, white 
and gray matter deposits of hemosiderin), enlarged perivascular spaces (cystic enlargement 
of the penetrating arteries, arterioles, veins and venules), recent small subcortical infarcts and 
post-ischemic damages in cortex, basal nuclei and white matter tracts. The article outlines dif-
fusion tensor MRI latest developments for cognitive deficits’ risk assessment, such as thresh-
old coefficients (indexes) of the fraction anisotropy, received in neocortex tracts (frontal and 
temporal lobes; fronto-thalamic pathway). 
Keywords: diffusion-tensor MRI, fractional anisotropy, vascular dementia, cognitive disor-
ders, brain atrophy, lacunar strokes, subcortical strokes, white matter hyperintensity.
Introduction
Increasing active life expectancy leads to the social significance of aging-associated 
diseases, such as senile dementia [1]. In the industrial countries, at the same time, con-
siderable part of disorders, provoking dementia  — besides neurodegenerative cerebral 
lesions — accounted for diseases of discirculatory character. This pathology is revealed 
not only for eldery patients, but also for a half of people aged from 50 to 65 years and for 
a quarter of population aged from 45 to 50 years. The main reason is chronic stress, which 
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plays one of the leading roles in pathogenesis of cardiovascular and cerebrovascular disor-
ders, associated with vascular endothelium damage. Cognitive disorders may be identified 
for patients with arterial hypertension even in young and middle age at earlier stages of 
chronic cerebral ischemia [2; 3]. Thus, primary task of clinical medicine is to provide maxi- 
mum possible early diagnostic of vascular brain damage, risk of initial cognitive deficit 
prediction for patients of young and middle age and prevention of dementia development, 
leading to disablement, for aged patients [4]. 
The importance of magnetic resonance tomography (MRI) for differential diagno-
sis of cerebral structures changes with certain damage patterns of cerebral cortex and 
pathways disease cannot be overestimated [5]. Even at initial stages of cerebral-vascular 
disease, when routine MRI is nonspecific, scarce and heterogenic  — it is possible to 
determine micro-structural changes in cerebral tracts, responsible for cognitive func-
tion. Detection of white matter tracts damages, non-visible in case of routine MRI ap-
plication, is possible unsing structural visualization technique — diffusion tensor MRI 
(DT-MRI) [6]. 
Current review contains the most prevalent and significant (for clinical medicine) 
neuroimaging markers, that could be detected using routine MRI and diffusion tensor 
MRI, and which could be predictors of cognitive dysfunction risk caused by cerebral vas-
cular diseases. 
Potential of the routine MRI
Using routine MRI, it is possible to obtain visual and quantitative estimate of mor-
phologic changes, which may be used as bio-markers of cerebral vascular lesions. Advan-
tage of the method is in its high diagnostic validity due to good contrast provided between 
different types of tissues [7]. 
Usually, diagnostics of the cognitive disorders caused by vascular diseases includes 
such specific markers as: diffusive atrophy of cortex (brain gray matter), atrophy of under-
lying structures (basal ganglion and deep pathways), white cerebral matter hyperintense 
(axons demyelination, transudative edema and gliosis), micro-haemorrhage (hemosi- 
derin and amyloid deposition along cerebral vasculars), extension of perivascular spaces, 
presence of “fresh” infarctions and post-ischemic lacunar lesion in strategic cortex zones, 
basal nuclei and white fiber fascicles, responsible for cognitive function [8]. 
Hyperintensity of the white matter (HWM)
HWM is a neuroimaging term, describing cerebral white matter structure changes, 
visible at Т2-weighted and FLAIR images as diffusive and local areas of hyperintensive 
(increased in respect of the rest vascular tissue) signal. These lesions are caused by the pro-
cesses of axon demyelinization leading to their atrophy and in case of vascular pathology 
they appeare in both brain hemispheres symmetrically. In 2013 the term “white matter 
hyper intensity” was proposed to be replaced the old names: “diffusive HWM” instead of 
“leukoaraiosis” and “local dotted or confluent HWM areas” instead of “foci of gliosis with 
dystrophic character”. This decision was accepted in accordance with recommendations 
of International expert committee for development of small vessel disease visualization 
criteria and standards (STRIVE — Standards for ReportIng Vascular changes on Euroim-
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aging) [9]. It is recommended to differ periventricular HWM and deeply localized HWM 
(at advanced stages, the difference between these types of changes disappears), what is as-
sociated with blood circulation features [10]. In 1987, famous Austrian neurologist Franz 
Fazekas proposed to use qualitative scale for estimation HWM degree in different brain 
zones [11]. 
Fazekas scale (F) — visual scale for evaluation of periventricular HWM and HWM of 
deep localization. The scale is used for MRI in Т2-weighted image mode (WI) with signal 
suppression from liquor — FLAIR or TIRM. HWM severity for deep localized white mat-
ter is estimated in the following way: F0 — HWM is absent; F1 — single foci of HWM, 
F2 — presence of both single and partially confluent foci of HWM, F3 — confluent foci of 
HWM (Fig. 1). For periventricular (PV) white matter: F0 — without HWM; F1 — small 
“caps” of HWM around ventricles’ horns; F2 — moderate confluent perventricular zones 
of HWM; F3 — massive “confluent” zones of HWM, propagating from ventricles up to 
subcortical divisions (Fig. 2).
Evaluation of the cerebral white matter changes using Fazekas scale has an impor-
tant prognostic value. According to Poggesi A., Gouw A. (2014) [12], HWM degree is 
Fig. 1. Fazekas scale (Deep) for HWM estimation in deep subcortical zones. Axial sections in TIRM 
mode. 
1 — single focus areas of HWM, 2 — presence of both single and partially confluent foci of HWM, 3 — confluent 
foci of HWM
Fig. 2. Fazekas scale (PV) for HWM estimation around ventricles. Axial sections in TIRM mode. 
1 — small HWM “caps” around ventricles’ horns; 2 — moderate confluent zones of HWM; 3 — massive “confluent” 
zones of HWM
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calculated as potential diagnostic indicator, correlated with cognitive disorder. Many 
authors associate double increase of dementia risk with augmenting of this trait [13; 
14]. HWM is revealed upon hypertensive microangiopathy and cerebeal amyloid an-
giopathy, general clinical implications of which are repetitive strokes and progressive 
cognitive decline [15]. In case of hereditary microangiopathy (CADASIL  — cerebral 
autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), 
where rough damage of white matter in anterior temporal, islet, external capsule and 
subcortical parts of the frontal lobes are main markers, HWM with diffuse charter man-
ifest already in young age and correlates with early cognitive disorders [16]. Presence 
of pronounced HWM with lesion of deep subcortical regions is associated with apathy, 
depression and other psychiatric disorders, based on frontal disfunction. For patients 
with discirculatory encephalopathy, extensiveness of HWM lesison correlates with hy-
perpiesis severity and cognitive disorders [17].
Atrophy of the brain matter
Atrophy of brain matter (cerebral cortex and deep brain structures) is a neuroimag-
ing indicator, accompanied by neurons loss and their axons as well, what makes it to be 
considered one of the pathological process markers, associated with cognitive disorders 
(Fig.  3). According to STRIVE, vascular pathology atrophic changes, characterized by 
progressing diffuse reduction of the head brain matter volume, are not associated with 
macroscopic local brain damages (such as trauma consequences or acute blood circula-
tion disorder) and can be estimated by enlargement of external and internal liquor spaces 
comparatively to intracranial volume.
Cortical atrophy leads to subarachnoid cavities’ and fissures increase, while volume 
of cerebral gyri decreases. Deep cerebral structures atrophy leads to increase of cerebrum 
lateral ventricles and the third ventricle. The latter causes frontal lobes function damage 
and its links with subcortical and stem divisions [18]. Internal hydrocephalus progres-
sion regarded as a more reliable criteria of cognitive disorders risk than visualization of 
focal subcortical HWM [19]. For rapid assessment of the atrophic lesions of deep cerebral 
tracts the following planimetric indications are sufficient: Index of lateral ventricle ante-
rior horns and the width of the III ventricle (Fig. 4).
Fig. 3. Diffusive atrophy of cerebral matter
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Anterior horns index (AHI) calculated by the for-
mula I/III х 100 — where I is a distance between lateral 
walls of lateral ventricle anterior horns; III  — maxi-
mum distance between internal bone plates of cal-
varium. Normal AHI indications for age group under 
60 years are — 24.0–26.3, for group of 61 to 80 years — 
28.2–29.4. 
Width of the third ventricle is measured at the axial 
section by drawing the line, perpendicular to cerebral 
fissure in the middle of the third ventricle. Normal 
width of the third ventricle is the following: < 7 mm for 
adults aged under 60; < 9 mm for adults aged 60+ [20]. 
For estimation of the cortical atrophic brain chan- 
ges and compensatory dilatation of the external sub-
arachnoid cavities, visual scale of global (diffusive) cor-
tical atrophy (GCA-scale) is applied, displaying changes 
from stage 1 to stage 4.
GCA-scale is a scale of the global cortical atrophy, 
which provides 13  cerebral zones estimation, genera- 
lizing brain changes in whole. Frontal, parieto-occipital 
and temporal sulci regions as well as ventricular system of each cerebral hemisphere were 
estimated separately using score from 0 to 3. Each of the anatomical structures mentioned 
above, estimated using the following scoring system: 0 — Normal volume / no ventricle 
expansion; 1 — sulci widening / moderate ventricle expansion; 2 — loss of sulci volume /
considerable ventricles widening; 3  — “knife blade” type atrophy /  expressed ventricle 
expansion (Fig. 5).
For now, the most accurate cortical atrophy estimation (especially for clinical ob-
servation in dynamics) requires MRI with application of specialized 3-D sequences and 
volumetric post-processing [21]. 
Fig.  4. Cerebral MR-image in 
axial projection obtained in T2-WI 
mode with determination of deep 
cerebral structures atrophy para- 
meters. Line I  — distance between 
lateral walls of lateral ventricle ante-
rior horns. Line II — measurement 
of the third ventricle width. Line 
III  — maximum distance between 
internal plates of calvarium bones
Fig. 5. Estimation of the cerebral atrophy severity using GCA-scale: 
1 — sulci widening / moderate ventricle widening; 2 — loss of sulci volume / considerable ventricles widening; 
3 — “knife blade” type atrophy / expressed ventricles widening
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Cerebral microbleeds
Cerebral microbleeds (CMB) manifested by small 
(diameter is usually 2 to 5 mm, sometimes — up to 10 mm) 
rounded foci with low МR-signal intensity, which can be 
revealed using Т2-weighted gradient recall echo images or 
other sequences, sensitive to magnetic fields heterogenei-
ties, for example, SWI sequence (Susceptibility Weighted 
Imaging) (Fig. 6). Most often these changes are localized 
subcortically, in deep white and gray matter, brain stem 
and cerebellum and can be associated with amyloid depo-
sition in vascular walls [22]. 
Cerebral microbleeds associated with aging and are 
typical for dementia progressing. For subjects with execu-
tive functions disorder this biomarker is detected predomi-
nately in frontal lobe and basal ganglia — areas, which are 
congenitally considered as neuroanatomical substrate for 
formation of cognitive, emotional and behavioral proces- 
ses. According to some authors, cerebral microbleeds are 
not only predictors of “lobe type” cognitive disorders associated with executive disfunction, 
but also of memory disorders, speech dysfunction and visual-spatial orientation [23; 24]. 
Perivascular spaces (PVS)
PVS — spaces filled by liquid, located downstream penetrating arteries, arterioles, 
veins and venules, surrounded by leptomeningeal membrane [25]. This biomarker (Fig. 7), 
visualized using routine MRI, is an indicator of microangiopathy and associated with in-
creasing risk of dementia development or cognitive function worsening [26]. Increasing 
perivascular spaces’ size and their widening associated with HWM abundance and lacu-
nar lesion can be considered as unfavorable prognostic sign [27]. 
Fig. 6. Subcortical and peri-
ventricular cerebral microbleeds 
at axial section (multiple hyperin-
tensive foci, visualized using SWI 
pulse sequence)
Fig.  7. Multiple widened perivascular spaces (bold arrows). Subcorti-
cal insular lobes (Т2-WI, axial projection) and parietal lobe (Т2-WI, sagittal 
projection)
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Lacunar cysts (LC) and recent small subcortical infarction
Lacunar type of dyscirculatory changes with multiple postischemic cysts in zones, 
significant for cognitive functions, is unfavorable prognostic sign. Vascular genesis LC is 
a round or oval cavity with perifocal gliosis ferrule and liquor content, with diameter 3 to 
15 mm (Fig. 8, 9А, 9B) [28; 29]. Perifocal gliosis around LC combined with no signs of 
MR-diffusion limitations signals that ischemic changes happen long time ago. 
For designating “fresh” ischemia focus (with diameter < 20 mm) a term “recent small 
subcortical infraction” was proposed  — infraction with clinical or neuroimaging data, 
confirming it was happened during last few weeks. To differentiate “fresh” and “old” fo-
cus (especially in respect of multi-foci cerebral lesion, when all foci conjugate between 
each other), DWI mode is preferable. DWI shows МR-diffusion signal amplification in 
the zone of blood circulation acute disorder at high (800, 1000) b-factor, while on ADC-
map this signal is declining (Fig. 9В). After a while this area transforms into lacunar cyst 
or into large focus of gliosis, but there will not be any restrictions of МR-diffusion in this 
zone [30].
Sporadic asymptomatic lacunar infarctions may lead to secondary degeneration of 
adjacent white matter sectors, what leads to cortico-nuclear tracts disintegration, integra-
Fig. 8. Lacunar postishemic cyst, filled by liquor in the area of left tha- 
lamus (Т2-weighted image, axial projection) and in the area of pons varolii 
(Т2-weighted image, sagittal projection)
Fig. 9. Post-ishemic character lacunar cyst, basal nuclei, on right (small arrow), recent focal infraction 
in periventricular area on left (large arrow). 
1 — Т2-WI mode, 2 — TIRM mode, 3 — DWI mode. To differ «fresh» and «old» focus is possible only using DWI 
mode
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tive cerebral activity and limbic system destruction because of associative fascicles inter-
ruption (among others — frontal thalamic pathway, ensuring bidirectional bond between 
nuclei of the thalamus, cingular gyrus and frontal cortex), decline of activating influence 
from the reticular formation and increase of cognitive disorders risk. Lacunar infarctions 
associated dementia manifested in such areas as: frontal lobes, parietal-temporal-occipital 
cerebral areas, mediobasal parts of temporal lobe, frontal and middle parts of thalami, 
pale globes, dentate nucleus of cerebellum hemisphere [31; 32].
Presence of any morphological anomaly increases patient’s disability or death risks, 
however, few or moderate amount of macro-changes, received using routine MRI, can 
complicate prognosis of cognitive disorders of vascular genesis. The reason is that mor-
phological substrates of chronic ischemic brain injury, resulting to cognitive deficit, are 
extremely non-specific. According to the data provided by some authors, standard MRI 
modes (Т2-WI, T2FLAIR, SWI) can be applied only for white matter visual estimation, 
being not sufficient to measure severity of damage. To solve this problem, another MRI 
methods using pulse sequences, which are more sensitive to micro-structural damages, 
are required [33]. 
Potential of the diffusion tensor MRI 
Diffusion tensor MRI shows micro-structural changes in axon myelin sheath and 
enables to estimate quantitatively severity of cerebral damages in a certain brain areas. The 
method provides application of pulse sequence in diffusion tensor imaging (DTI) with 
measuring dffusion in several directions and subsequent processing using post-process-
ing programms, that provides opportunity to obtain certain numerical values of fractional 
anisotropy coefficient (CFA) and mean diffusion coefficient (MDC) in any region of inte- 
rest [34]. 
The lower is CFA, the more the structure of cerebral tracts can be damaged. That’s 
why DT-MRI is the most relevant method to detect the disease progression, demonstra-
ting impressive potential for discirculatory damage severity differentiation [35]. Investiga-
tion of the pathophysiological mechanisms of cognitive dysfunction augmentation, steady 
correlation between severity of microstructural changes of main white matter tracts and 
clinical disorders was found. That fact proves advisability of DT-MRI use to detect disease 
already from subclinical lesion of cerebral structures stage [36].
Neocortical structures of fronto-temporal lobes are considered as strategically sig-
nificant for cognitive activity [37]. Some authors highlighted three zones, responsible for 
cognitive function: Аnterior Corona Radiata (ACR) (fig.10, zone 1), inferior longitudinal 
fascicle (ILF) (Fig. 10, zone 2) and Anterior Limb of the Internal Capsule (ALIC) (Fig. 10, 
zone 3). According to their data, investigating microstructural changes in these fascicles, 
it is possible to determine diagnostic ranges of vascular genesis’ cognitive disorders deve- 
lopment risk and to define CFA threshold absolute values [38], or their indices in respect 
to region of interest.
Indices of fractional anisotropy coefficient (CFA) as cognitive disorders markers. Us-
ing indices instead of absolute CFA values is more practical and less complicated method: 
the results not depend anymore of possible measurement difference, that can appear be-
cause of different magnetic field strength, or when equipment of different MRI producers 
is used; certain special methods to measure CFA manually are not required (that is con-
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venient for operator). And, what is most important — it can be applied to evaluate status 
of certain patient, without collecting groups of control or using some “reference” CFA 
values for each region of interest. But for receiving indices some “stable” region is needed. 
In a number of investigations [39] splenium of corpus callosum (SCC) was determined 
as a region of least variable anisotropy, not depending upon vascular pathology and other 
age-related changes (Fig. 10). 
Fig. 10. Black and white map of factional anisotropy in axial projection. 
1 — Аnterior Corona Radiata (ACR), 2 — Inferior Longitudinalis Fasciculus (ILF), 3 — Anterior Limb of the 
Internal Capsule (ALIC), 4 — central parts of splenium of corpus callosum
Fig.  11. Threshold values of CFA indices for Аnterior Corona Radiata 
(ACR) as neuroimaging markers of cognitive impairment risk
Fig. 12. Threshold values of CFA indexes for Inferior Longitudinalis Fascicu-
lus (ILF) as neuroimaging markers of cognitive impairment risk
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CFA indices are obtained by calculating ratio of CFA value in certain tract to the CFA 
value in splenium of corpus callosum for the same patient (Fig. 11, Fig. 12, Fig. 13). The 
boarders of risk intervals of cognitive decline in regions of interest (CFA indices) 
showing in the table below.
Table. Cognitive decline risk in CFA indices
Regions of interest No risk of cognitive disorder
Initial risk of cognitive 
disorder
High risk of cognitive 
disorder (or there 
is already a disease)
Аnterior Corona Radiata 
(ACR) > 0.44 0.44–0.34 < 0.34
Inferior Longitudinal 
Fasciculus (ILF) > 0.59 0.59–0.47 < 0.47
Anterior Limb of the 
Internal Capsule (ALIC) > 0.71 0.71–0.65 < 0.65
Entering into initial risk interval of cognitive decline tells that it is necessary to take 
appropriate measures to prevent disease. At this stage patient must be additionally exami- 
ned, including neuropsychological tests, and it is necessary to assign appropriate care 
recommendations and life style changing, intellectual exercises and memory training to 
increase cognitive reserve, preventing progress of accompanying pathology, influencing 
cerebral blood supply. Going out through the lower threshold values boarder of the CFA 
index in one or in all three zone may signal about severity of already presented cognitive 
disorder, that also require correction of the therapy [39].
Cerebral tracts’ microstructural changes may also be detected using DT-МRI even 
before patients’ claims on cognitive function decline. CFA indices and its absolute valu- 
es changes can be indicators of latent pathological changes of nerve cells axons, taking 
place at initial stage of demyelinization, caused by vascular pathology. Application of 
Fig.  13. Threshold values of CFA indexes for Anterior Limb of the Internal 
Capsule (ALIC) as neuroimaging markers of cognitive impairment risk
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such vascular dementia neuroimaging markers provides an opportunity to have cogni-
tive disorders prognosis and to make timely decisions on patient therapy and care [40].
Conclusions
Modern methods of structural visualization successfully supplement each other and 
may provide early detection of dementia, assisting to refine and to broaden our beliefs 
concerning pathophysiological processes, uderlaying cognitive dysfunction formation. 
Microstructural changes in cerebral pathways may also be detected using DTI before pa-
tients’ active claims on cognitive function decline. This is important stage of diagnostic as-
sistance for successful therapy of this disease for aged patients, as well as for its prevention 
for people of young and middle age.
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